Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
28.39
+0.32 (1.14%)
At close: May 9, 2025, 4:00 PM
28.77
+0.38 (1.34%)
After-hours: May 9, 2025, 7:20 PM EDT

Fresenius Medical Care AG Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
19,49319,33619,45419,39817,61917,859
Upgrade
Revenue Growth (YoY)
0.10%-0.60%0.29%10.10%-1.35%2.19%
Upgrade
Cost of Revenue
14,72614,57914,52914,50412,84612,322
Upgrade
Gross Profit
4,7674,7574,9254,8944,7735,537
Upgrade
Selling, General & Admin
3,1183,1433,1963,1702,7732,966
Upgrade
Research & Development
179.17183.49231.97228.62220.78193.77
Upgrade
Other Operating Expenses
-89.68-109.03-26.86-43.25-124.41-
Upgrade
Operating Expenses
3,2073,2173,4013,3562,8693,160
Upgrade
Operating Income
1,5601,5391,5241,5381,9042,378
Upgrade
Interest Expense
-398.91-407.04-424.64-360.14-353.6-409.98
Upgrade
Interest & Investment Income
70.8971.5888.2267.6673.1741.96
Upgrade
Earnings From Equity Investments
153.87134.88121.7966.5692.1894.52
Upgrade
Currency Exchange Gain (Loss)
-21.58-23.06-35.5-36.83-9.9-
Upgrade
EBT Excluding Unusual Items
1,3641,3161,2731,2751,7062,104
Upgrade
Merger & Restructuring Charges
-190.06-317.48-259.92-147.95-37.55-
Upgrade
Impairment of Goodwill
------193.98
Upgrade
Gain (Loss) on Sale of Investments
-38.7844.0314.6744.85-87.63-
Upgrade
Gain (Loss) on Sale of Assets
14.714.664.8447.17-8.63-
Upgrade
Asset Writedown
------3.25
Upgrade
Other Unusual Items
-----29.41
Upgrade
Pretax Income
1,1501,0571,0331,2191,5721,936
Upgrade
Income Tax Expense
337.59316.06300.56324.95352.83500.56
Upgrade
Earnings From Continuing Operations
812.16740.87732.46894.331,2191,436
Upgrade
Minority Interest in Earnings
-193.99-202.96-233.46-220.92-249.72-271.46
Upgrade
Net Income
618.18537.91499673.41969.311,164
Upgrade
Net Income to Common
618.18537.91499673.41969.311,164
Upgrade
Net Income Growth
27.83%7.80%-25.90%-30.53%-16.75%-2.94%
Upgrade
Shares Outstanding (Basic)
293293293293293294
Upgrade
Shares Outstanding (Diluted)
293293293293293294
Upgrade
Shares Change (YoY)
--0.06%0.06%-0.41%-2.80%
Upgrade
EPS (Basic)
2.111.831.702.303.313.96
Upgrade
EPS (Diluted)
2.111.831.702.303.313.96
Upgrade
EPS Growth
27.83%7.65%-25.97%-30.60%-16.44%-0.01%
Upgrade
Free Cash Flow
1,7101,6871,9441,4431,6353,181
Upgrade
Free Cash Flow Per Share
5.835.756.634.925.5810.81
Upgrade
Dividend Per Share
1.4401.4401.1901.1201.3501.340
Upgrade
Dividend Growth
21.01%21.01%6.25%-17.04%0.75%11.67%
Upgrade
Gross Margin
24.45%24.60%25.32%25.23%27.09%31.01%
Upgrade
Operating Margin
8.00%7.96%7.83%7.93%10.81%13.31%
Upgrade
Profit Margin
3.17%2.78%2.56%3.47%5.50%6.52%
Upgrade
Free Cash Flow Margin
8.77%8.72%9.99%7.44%9.28%17.81%
Upgrade
EBITDA
2,3622,3472,3792,5122,7993,261
Upgrade
EBITDA Margin
12.12%12.14%12.23%12.95%15.88%18.26%
Upgrade
D&A For EBITDA
802.18807.31855.58973.66894.89882.87
Upgrade
EBIT
1,5601,5391,5241,5381,9042,378
Upgrade
EBIT Margin
8.00%7.96%7.83%7.93%10.81%13.31%
Upgrade
Effective Tax Rate
29.36%29.90%29.09%26.65%22.45%25.85%
Upgrade
Revenue as Reported
19,49319,33619,45419,39817,61917,859
Upgrade
Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q